Veradigm Debt to Equity Ratio 2010-2022 | MDRX
Current and historical debt to equity ratio values for Veradigm (MDRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Veradigm debt/equity for the three months ending December 31, 2022 was 0.00.
Veradigm Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-12-31 |
$0.49B |
$1.02B |
0.48 |
2022-09-30 |
$0.51B |
$1.18B |
0.44 |
2022-06-30 |
$0.52B |
$1.20B |
0.43 |
2022-03-31 |
$1.08B |
$1.35B |
0.80 |
2021-12-31 |
$0.95B |
$1.36B |
0.70 |
2021-09-30 |
$1.07B |
$1.42B |
0.75 |
2021-06-30 |
$1.15B |
$1.39B |
0.82 |
2021-03-31 |
$1.19B |
$1.68B |
0.71 |
2020-12-31 |
$1.25B |
$1.67B |
0.75 |
2020-09-30 |
$1.94B |
$1.21B |
1.60 |
2020-06-30 |
$1.95B |
$1.24B |
1.57 |
2020-03-31 |
$2.01B |
$1.24B |
1.62 |
2019-12-31 |
$1.92B |
$1.29B |
1.49 |
2019-09-30 |
$1.95B |
$1.28B |
1.52 |
2019-06-30 |
$1.92B |
$1.32B |
1.46 |
2019-03-31 |
$1.79B |
$1.46B |
1.23 |
2018-12-31 |
$1.60B |
$1.58B |
1.01 |
2018-09-30 |
$3.40B |
$1.12B |
3.05 |
2018-06-30 |
$3.21B |
$1.14B |
2.81 |
2018-03-31 |
$3.26B |
$1.11B |
2.94 |
2017-12-31 |
$3.07B |
$1.16B |
2.65 |
2017-09-30 |
$2.74B |
$1.15B |
2.39 |
2017-06-30 |
$2.62B |
$1.17B |
2.25 |
2017-03-31 |
$2.61B |
$1.19B |
2.20 |
2016-12-31 |
$2.56B |
$1.27B |
2.01 |
2016-09-30 |
$2.44B |
$1.37B |
1.78 |
2016-06-30 |
$2.36B |
$1.35B |
1.75 |
2016-03-31 |
$1.24B |
$1.39B |
0.89 |
2015-12-31 |
$1.26B |
$1.42B |
0.89 |
2015-09-30 |
$1.28B |
$1.40B |
0.92 |
2015-06-30 |
$1.31B |
$1.39B |
0.94 |
2015-03-31 |
$1.23B |
$1.28B |
0.96 |
2014-12-31 |
$1.18B |
$1.28B |
0.92 |
2014-09-30 |
$1.29B |
$1.28B |
1.00 |
2014-06-30 |
$1.29B |
$1.30B |
1.00 |
2014-03-31 |
$1.33B |
$1.31B |
1.02 |
2013-12-31 |
$1.30B |
$1.32B |
0.99 |
2013-09-30 |
$1.31B |
$1.33B |
0.98 |
2013-06-30 |
$1.31B |
$1.37B |
0.96 |
2013-03-31 |
$1.29B |
$1.33B |
0.97 |
2012-12-31 |
$1.07B |
$1.28B |
0.83 |
2012-09-30 |
$1.11B |
$1.30B |
0.85 |
2012-06-30 |
$1.20B |
$1.28B |
0.94 |
2012-03-31 |
$1.06B |
$1.49B |
0.71 |
2011-12-31 |
$1.03B |
$1.48B |
0.70 |
2011-09-30 |
$0.99B |
$1.44B |
0.69 |
2011-06-30 |
$1.04B |
$1.41B |
0.74 |
2011-03-31 |
$1.02B |
$1.43B |
0.71 |
2010-12-31 |
$1.04B |
$1.38B |
0.75 |
2010-09-30 |
$1.01B |
$1.37B |
0.74 |
2010-06-30 |
$0.00B |
|
0.00 |
2010-05-31 |
$0.29B |
$0.81B |
0.36 |
2010-03-31 |
$0.00B |
|
0.00 |
2010-02-28 |
$0.24B |
$0.79B |
0.31 |
2009-12-31 |
$0.21B |
$0.77B |
0.27 |
2009-11-30 |
$0.21B |
$0.77B |
0.27 |
2009-09-30 |
$0.00B |
|
0.00 |
2009-08-31 |
$0.23B |
$0.74B |
0.31 |
2009-05-31 |
$0.25B |
$0.70B |
0.36 |
2009-02-28 |
$0.26B |
$0.72B |
0.36 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Information Systems |
$0.482B |
$0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO.
|